GlassScriptPhysician profile
Alan C Wittgrove
NPI 1942287206
$157,222.52
in general payments reported to CMS, 2019-2025
35 companies · $1,717 in 2025
The $1,717 reported for 2025 was more than what 80% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34K · 2020: $18K · 2021: $32K · 2022: $14K · 2023: $22K · 2024: $35K · 2025: $1,717.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $50K · Travel and Lodging: $3,545 · Food and Beverage: $3,410 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $49,729.39 |
| Travel and Lodging | $3,544.63 |
| Food and Beverage | $3,410.09 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $132,480.98 | 2019-2024 | Echelon Flex, Harmonic, Echelon Endopath |
| Senseonics, Incorporated | $9,173.00 | 2019-2025 | Eversense |
| Ethicon INC. | $5,366.61 | 2019-2022 | |
| Ethicon US, LLC | $3,859.24 | 2019-2025 | Echelon; Endopath, Harmonic, Surgiflo Hemostatic Matrix |
| Ethicon Endo-Surgery INC. | $1,725.00 | 2022 | |
| Medtronic, INC. | $1,263.52 | 2022-2023 | |
| Currax Pharmaceuticals LLC | $482.53 | 2020-2025 | Contrave |
| Covidien LP | $443.13 | 2019-2020 | |
| Janssen Biotech, INC. | $333.67 | 2022-2025 | Tremfya, Simponi Aria, Stelara |
| Novo Nordisk INC | $328.94 | 2021-2025 | Wegovy, Saxenda |
| Mallinckrodt Hospital Products INC. | $290.28 | 2022-2025 | Acthar |
| Teleflex LLC | $231.69 | 2019-2025 | Titan Sgs Bailout Chuck, Titan Sgs Standard Gastric Stapler |
| Lilly USA, LLC | $189.78 | 2023-2025 | Zepbound, Taltz, Olumiant |
| Ucb, INC. | $161.24 | 2022-2025 | Cimzia, Bimzelx |
| Redhill Biopharma INC. | $113.57 | 2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascensia Diabetes Care US INC. | $112.17 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $97.88 | 2024 | |
| Octapharma USA, INC. | $69.03 | 2024 | Octagam Immune Globulin (Human) |
| Nalpropion Pharmaceuticals LLC | $68.29 | 2019 | |
| Karl Storz Endoscopy-America | $57.95 | 2022 | |
| Amgen INC. | $42.41 | 2022-2023 | Tavneos |
| Kyowa Kirin, INC. | $41.99 | 2023-2025 | |
| Genzyme Corporation | $40.56 | 2024-2025 | |
| Ani Pharmaceuticals, INC. | $29.74 | 2025 | Purified Cortrophin Gel |
| Astrazeneca Pharmaceuticals LP | $25.80 | 2025 | Saphnelo |
| Grifols USA, LLC | $23.00 | 2024 | Gamunex-C |
| Takeda Pharmaceuticals U.S.A., INC. | $22.80 | 2023 | Gattex |
| Baxter Healthcare | $22.63 | 2022 | |
| Fidia Pharma USA INC. | $21.54 | 2023 | Hymovis |
| Aurinia Pharma U.S., INC. | $19.47 | 2024 | Lupkynis |
| Glaxosmithkline, LLC. | $19.06 | 2022 | |
| Intra-Sana Laboratories | $17.71 | 2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Avanos Medical | $17.40 | 2023 | Trivisc Sodium Hyaluronate |
| Sobi, INC | $17.28 | 2024 | |
| Levita Magnetics International Corp | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Wittgrove listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.